SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-21-004585
Filing Date
2021-04-22
Accepted
2021-04-22 07:03:55
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20210422xdefa14a.htm DEFA14A 31183
2 GRAPHIC tmb-20210422xdefa14a002.jpg GRAPHIC 87200
3 GRAPHIC tmb-20210422xdefa14a001.jpg GRAPHIC 119080
  Complete submission text file 0001558370-21-004585.txt   316486
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37581 | Film No.: 21843238
SIC: 2834 Pharmaceutical Preparations